These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8738668

  • 21. [Circadian behavior of blood pressure and heart rate following orthotopic heart transplantation. Studies before and during antihypertensive therapy].
    Angermann CE, Spes CH, Willems S, Dominiak P, Kemkes BM, Theisen K.
    Z Kardiol; 1989 Apr; 78(4):228-35. PubMed ID: 2544062
    [Abstract] [Full Text] [Related]

  • 22. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
    Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
    [Abstract] [Full Text] [Related]

  • 23. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 24. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 25. Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?
    Martins L, Ventura A, Branco A, Carvalho MJ, Henriques AC, Dias L, Sarmento AM, Amil M.
    Transplant Proc; 2004 May; 36(4):877-9. PubMed ID: 15194300
    [Abstract] [Full Text] [Related]

  • 26. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA, Gimson AE, Gibbs P, Alexander GJ.
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [Abstract] [Full Text] [Related]

  • 27. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 28. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S.
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [Abstract] [Full Text] [Related]

  • 29. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 30. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 31. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A.
    Transplantation; 2003 Nov 15; 76(9):1320-6. PubMed ID: 14627910
    [Abstract] [Full Text] [Related]

  • 32. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing.
    Bunke M, Sloan R, Brier M, Ganzel B.
    Transplantation; 1995 Feb 27; 59(4):537-40. PubMed ID: 7878758
    [Abstract] [Full Text] [Related]

  • 33. Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients.
    Mendes J, Martinho A, Simoes O, Mota A, Breitenfeld L, Pais L.
    Transplant Proc; 2009 Apr 27; 41(3):840-2. PubMed ID: 19376366
    [Abstract] [Full Text] [Related]

  • 34. Oral health status, oral microflora, and non-surgical periodontal treatment of renal transplant patients receiving cyclosporin A and FK506.
    Chu FC, Tsang PC, Chan AW, Leung WK, Samaranayake LP, Chan TM.
    Ann R Australas Coll Dent Surg; 2000 Oct 27; 15():286-91. PubMed ID: 11709958
    [Abstract] [Full Text] [Related]

  • 35. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 27; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 36. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
    Ji SM, Li LS, Sha GZ, Chen JS, Liu ZH.
    Transplant Proc; 2007 Jun 27; 39(5):1402-5. PubMed ID: 17580148
    [Abstract] [Full Text] [Related]

  • 37. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G, Nart A, Uslu A, Onman T, Aykas A, Doğan M, Karaca B.
    Transplant Proc; 2008 Jun 27; 40(1):151-5. PubMed ID: 18261573
    [Abstract] [Full Text] [Related]

  • 38. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
    Sommerer C, Zeier M, Meuer S, Giese T.
    Transplantation; 2010 Jun 15; 89(11):1417-23. PubMed ID: 20463649
    [Abstract] [Full Text] [Related]

  • 39. [Fatty acid profile in phospholipids fraction with regard to blood pressure control in the kidney transplant patients].
    Wilusz M, Cieniawski D, Ignacak E, Bugajska J, Berska J, Bętkowska-Prokop A, Kużniewski M, Sułowicz W, Sztefko K.
    Przegl Lek; 2016 Jun 15; 73(9):621-6. PubMed ID: 29688661
    [Abstract] [Full Text] [Related]

  • 40. Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.
    O'Gorman MA, Fivush B, Wise B, Colombani P, Burdick J, Schwarz KB.
    Clin Transplant; 1995 Aug 15; 9(4):312-6. PubMed ID: 7579739
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.